Relation promises 'transformationally different success rates' in expanded AI pact with GSK

David Roblin, Relation CEO July 30, 2026 07:12 AM EDT R&DAI Re­la­tion promis­es 'trans­for­ma­tion­al­ly dif­fer­ent suc­cess rates' in ex­pand­ed AI pact with GSK Elizabeth Cairns Senior biopharma journalist GSK is set to pay Re­la­tion Ther­a­peu­tics up to $110 mil­lion to ex­pand their ex­ist­ing part­ner­ship to use AI mod­el­ing for drug dis­cov­ery. Un­der the … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER